ProShare Advisors LLC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 121 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$73,971
+53.1%
15,475
+36.1%
0.00%
Q2 2023$48,314
-16.0%
11,368
+5.0%
0.00%
Q1 2023$57,507
-25.3%
10,830
-11.7%
0.00%
Q4 2022$77,012
-35.3%
12,263
+8.5%
0.00%
Q3 2022$119,000
+101.7%
11,300
+4.7%
0.00%
Q2 2022$59,000
-59.3%
10,793
-31.5%
0.00%
Q1 2022$145,000
-25.6%
15,766
+22.1%
0.00%
Q4 2021$195,00012,9100.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q2 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 474,067$2,014,78515.70%
Memorial Sloan Kettering Cancer Center 544,196$2,312,8337.30%
Elmwood Wealth Management, Inc. 2,364,415$10,048,7644.68%
PFM Health Sciences, LP 5,570,869$23,676,1930.92%
Avidity Partners Management LP 2,758,600$11,724,0500.41%
Green Alpha Advisors, LLC 105,826$449,7600.30%
Bruce & Co., Inc. 200,000$850,0000.24%
SVB FINANCIAL GROUP 20,714$88,0350.17%
Rokos Capital Management LLP 2,748,139$11,202,7890.11%
Tekla Capital Management LLC 567,147$2,410,3750.09%
View complete list of CARIBOU BIOSCIENCES INC shareholders